Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response.

ABSTRACT: Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response.

PROVIDER: PRJNA1083998 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28230801.fastq.gz	Fastqsanger.gz
	SRR28230802.fastq.gz	Fastqsanger.gz
	SRR28230803.fastq.gz	Fastqsanger.gz
	SRR28230804.fastq.gz	Fastqsanger.gz
	SRR28230805.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 36

Similar Datasets

Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response.

Project description:The egl-9 family hypoxia-inducible factor (EGLN) enzymes, also known as prolyl hydroxylase domain (PHD) enzymes, are metabolic sensors regulating inflammatory responses and cellular metabolism. Both neuroinflammation and dysregulated energy metabolism are linked to motor neuron degeneration leading to amyotrophic lateral sclerosis (ALS) and correlate with disease progression. Therefore, the aim of this study was to explore the role of EGLN2 in ALS. Using a genetic and an oligonucleotide-based approach, we showed that downregulation of EGLN2 protects motor neurons and mitigates the ALS-like phenotypes in a mouse and a zebrafish model of ALS. Single-nuclei RNA sequencing of murine spinal cord revealed that loss of EGLN2 induced an astrocyte-specific downregulation of pro-inflammatory interferon-stimulated genes. In addition, we found that genetic deletion of EGLN2 restored the disturbed interferon response in iPSC-derived astrocytes from an ALS patient, confirming the novel link between EGLN2 and astrocytic interferon signaling. In conclusion, we identified EGLN2 as a potential novel ALS therapeutic target normalizing the astrocytic interferon-dependent inflammatory axis in vivo as well as in patient-derived cells.

2024-09-05 | GSE260913 | GEO

Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response

2024-09-09 | GSE219201 | GEO

Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response

Project description:Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response

| PRJNA907390 | ENA

Cell-penetrant SELENOT mimetic protects dopaminergic neurons and ameliorates motor function

Project description:Cell-penetrant SELENOT mimetic protects dopaminergic neurons and ameliorates motor function

| PRJNA637314 | ENA

Astrocytic heterogeneous nuclear ribonucleoprotein U facilitates scar formation after spinal cord injury

Project description:In this study, by a genome-wide RNA interference screen, we identified heterogeneous nuclear ribonucleoprotein U (Hnrnpu) as an endogenous key molecule in astrocyte activation. Inhibition of Hnrnpu in astrocytes impairs the formation of astrocytic glial scar, motor function recovery, and neuronal regeneration after spinal cord injury (SCI) in mice. Therefore, we then performed gene expression profiling analysis to evalute the function of HNRNPU in human astrocytes. Our findings uncover that modulation of endogenous astrocytic function through Hnrnpu would be a promising therapeutic avenue to restore neurological function after the injury.

2025-01-28 | GSE236433 | GEO

Dupilumab normalizes the eosinophilic esophagitis disease transcriptome

Project description:Dupilumab, which blocks interleukin (IL)-4 and IL-13 signaling, is approved in eosinophilic esophagitis (EoE) and several other type 2 inflammatory diseases. We show that dupilumab normalizes the dysregulated esophageal transcriptome in pediatric, adolescent, and adult patients with EoE, including both eosinophil-related and eosinophil-independent biologic pathways.

2025-10-01 | GSE303734 | GEO

Membralin deficiency dysregulates astrocytic glutamate homeostasis leading to ALS-like impairment

Project description:Mechanisms underlying motor neuron degeneration in amyotrophic lateral sclerosis (ALS) are yet unclear. Specific deletion of the ER-component membralin in astrocytes manifested postnatal motor defects and lethality in mice, causing the accumulation of extracellular glutamate through reducing the glutamate transporter EAAT2. Restoring EAAT2 levels in membralin KO astrocytes limited astrocyte-dependent excitotoxicity in motor neurons. Transcriptomic profiles from mouse astrocytic membralin KO motor cortex indicateed significant perturbation in KEGG pathway components related to ALS, including downregulation of Eaat2 and upregulation of Tnfrsf1a. Changes in gene expression with membralin deletion also overlapped with mouse ALS models and reactive astrocytes. Our results shown that activation of TNF receptor (TNFR1)-NFkB pathway known to suppress Eaat2 transcription was upregulated with membralin deletion. Further, reduced membralin and EAAT2 levels correlated with disease progression in spinal cord from SOD1-mutant mouse models, and reductions in membralin/EAAT2 were observed in human ALS spinal cord. Importantly, overexpression of membralin in SOD1G93A astrocytes decreased TNFR1 levels and increased EAAT2 expression, and improved motor neuron survival. Importantly, upregulation of membralin in SOD1G93A mice significantly prolonged mouse survival. Together, our study provides a mechanism for ALS pathogenesis where membralin limits glutamatergic neurotoxicity, suggesting that modulating membralin has potential in ALS therapy

2019-05-07 | GSE130763 | GEO

Dynamic astrocytic gene expression profiles after ischemic stroke

Project description:Analysis of astrocytic gene expression profiles after ischemic stroke. Stroke is a complicated disease caused by the interaction of multiple celltypes. Results provide new insights into the molecular mechanisms underlying astrocytic activation after ischemic stroke.

2024-05-23 | GSE238125 | GEO

Genome-Wide Profiling of Astrocytic Gliomas

Project description:Genomic aberrations were determined by array-based comparative genomic hybridization in 131 diffuse astrocytic gliomas, including 87 primary glioblastomas (pGBIV), 13 secondary glioblastomas (sGBIV), 19 anaplastic astrocytomas (AAIII), and 12 diffuse astrocytomas (AII). Expression profiling was performed for 74 tumors (42 pGBIV, 11 sGBIV, 13 AAIII, 8 AII). 131 aCGH experiments. 87 EP experiments (x2 dye swap). DNA and RNA extracted from the same patients.

2010-09-14 | E-GEOD-18166 | biostudies-arrayexpress

Dupilumab normalizes the eosinophilic esophagitis disease transcriptome

Project description:Dupilumab normalizes the eosinophilic esophagitis disease transcriptome

| PRJNA1297184 | ENA